Global /Egypt /Healthcare /Drug Manufacturers - General /NIPH

EI- Nile Co. for Pharmaceuticals and Chemical Industries

NIPH

• EGX: NIPH • Delayed

124.20EGP -0.9%

2.39 USD

As of 10 June 2026, EI- Nile Co. for Pharmaceuticals and Chemical Industries has a market cap of $119.3M USD, ranking #24299 globally and #90 in Egypt. It ranks #2171 in the Healthcare sector, and #787 in the Drug Manufacturers - General industry.

Global Rank

24299

Country Rank

Sector Rank

2171

Industry Rank

787

Key Stats

Market Cap

$119.3MUSD

6.21B EGP

Enterprise Value

$142.27MUSD

7.41B EGP

Revenue (TTM)

$37.91MUSD

1.97B EGP

EBITDA (TTM)

$10.44MUSD

543.33M EGP

Net Income (TTM)

$4.4MUSD

229.13M EGP

EBITDA Margin

28%

Profit Margin

12%

PE Ratio

27.1

PS Ratio

3.1

PB Ratio

6.0

EV/EBITDA

13.6

Company Profile

Country (HQ)

Egypt

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Khaled Hajjaj open_in_new

Employees

2,500

Founded

1962

Website

nilepharma.com.eg open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.9%	-2.2%	30%	30%	-14%	24%	153%	213%	260%

News

Markets

Exchange	Ticker	Price	Quotes
Egyptian Exchange (EGX) MIC: XCAI PRIMARY	NIPH النيل للادوية والصناعات الكيماوية - النيل ISIN: EGS38331C012 Shares Out.: Shares Outstanding: 50.0M¹ Shares Float: 14.167M² TV: TradingView: EGX: NIPH SA: Stock Analysis: EGX: NIPH YF: Yahoo Finance: NIPH GF: Google Finance: EGX: NIPH BA: Barron's: NIPH MS: Morningstar: XCAI: NIPH	124.20 EGP	TV: TradingView: EGX: NIPH SA: Stock Analysis: EGX: NIPH YF: Yahoo Finance: NIPH GF: Google Finance: EGX: NIPH BA: Barron's: NIPH MS: Morningstar: XCAI: NIPH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About EI- Nile Co. for Pharmaceuticals and Chemical Industries

EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt. The company offers manufacturing, research and development, training, and biotechnology solutions. It also exports its products to the countries in the Middle East. The company was founded in 1962 and is based in Cairo, Egypt.

Similar Companies

Industry: Drug Manufacturers - General (Egypt)

Name	Market Cap (USD) diff.	PE	Country
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) EGX: RMDA	$174.82M 9.1B EGP 47%	34.1	Egypt
MINAPHARM Pharmaceuticals EGX: MIPH	$134.86M 7.02B EGP 13%	58.9	Egypt
Kahira Pharmaceuticals & Chemical Industries Co. EGX: CPCI	$89.94M 4.68B EGP -25%	10.0	Egypt
Alexandria Co. For Pharmaceuticals & Chemical Industries EGX: AXPH	$85.83M 4.47B EGP -28%	9.0	Egypt
Memphis Pharmaceuticals & Chemical Industries EGX: MPCI	$74.54M 3.88B EGP -38%	7.5	Egypt
October Pharma S.A.E EGX: OCPH	$71.48M 3.72B EGP -40%	22.5	Egypt

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 638K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 459K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 302K%	97.4	United States
Roche Holding AG SIX: RO	$321.17B 256.25B CHF 269K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.57B 215.59B GBP 241K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.35B 218.9B CHF 230K%	20.5	Switzerland

chevron_leftBack